Cite
Klein R, Horak K, Lee KE, et al. The Relationship of Serum Soluble Receptor for Advanced Glycation End Products (sRAGE) and Carboxymethyl Lysine (CML) to the Incidence of Diabetic Nephropathy in Persons With Type 1 Diabetes. Diabetes Care. 2017;40(9):e117-e119doi: 10.2337/dc17-0421.
Klein, R., Horak, K., Lee, K. E., Danforth, L., Cruickshanks, K. J., Tsai, M. Y., Gangnon, R. E., & Klein, B. E. K. (2017). The Relationship of Serum Soluble Receptor for Advanced Glycation End Products (sRAGE) and Carboxymethyl Lysine (CML) to the Incidence of Diabetic Nephropathy in Persons With Type 1 Diabetes. Diabetes care, 40(9), e117-e119. https://doi.org/10.2337/dc17-0421
Klein, Ronald, et al. "The Relationship of Serum Soluble Receptor for Advanced Glycation End Products (sRAGE) and Carboxymethyl Lysine (CML) to the Incidence of Diabetic Nephropathy in Persons With Type 1 Diabetes." Diabetes care vol. 40,9 (2017): e117-e119. doi: https://doi.org/10.2337/dc17-0421
Klein R, Horak K, Lee KE, Danforth L, Cruickshanks KJ, Tsai MY, Gangnon RE, Klein BEK. The Relationship of Serum Soluble Receptor for Advanced Glycation End Products (sRAGE) and Carboxymethyl Lysine (CML) to the Incidence of Diabetic Nephropathy in Persons With Type 1 Diabetes. Diabetes Care. 2017 Sep;40(9):e117-e119. doi: 10.2337/dc17-0421. Epub 2017 Jun 19. PMID: 28630056; PMCID: PMC5566284.
Copy
Download .nbib